May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Adenovirus Keratitis in the C57BL/6J Mouse
Author Affiliations & Notes
  • J. Chodosh
    Molecular Pathogenesis of Eye Infection Research Center, University of Oklahoma Health Sciences Center – Dean A. McGee Eye Institute, Oklahoma City, OK
  • A.V. Chintakuntlawar
    Molecular Pathogenesis of Eye Infection Research Center, University of Oklahoma Health Sciences Center – Dean A. McGee Eye Institute, Oklahoma City, OK
  • R.A. Astley
    Molecular Pathogenesis of Eye Infection Research Center, University of Oklahoma Health Sciences Center – Dean A. McGee Eye Institute, Oklahoma City, OK
  • Footnotes
    Commercial Relationships  J. Chodosh, None; A.V. Chintakuntlawar, None; R.A. Astley, None.
  • Footnotes
    Support  Research to Prevent Blindness, and NIH Grants P30 EY12190, and RO1 EY13124
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2651. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Chodosh, A.V. Chintakuntlawar, R.A. Astley; Adenovirus Keratitis in the C57BL/6J Mouse . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2651.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Epidemic keratoconjunctivitis (EKC) is a highly contagious disease caused by human adenovirus (HAdV) serotypes 8, 19, and 37, and is characterized by acute keratoconjunctivitis and delayed onset, corneal subepithelial infiltrates. Inflammation after adenoviral gene therapy and in clinical HAdV infections may occur independently of viral replication. This study was designed to determine if an ocular HAdV would induce keratitis in the mouse, despite an absence of viral replication.

Methods: : C57BL/6J mice, aged 8–12 weeks, were injected with various concentrations of cesium chloride gradient–purified HAdV–37 or buffer into their corneal stroma, using a gas powered micro–injection system. Mice were examined for signs of corneal inflammation, and the expression of chemokine/cytokine mRNA and protein in the cornea determined by real–time PCR and multiplex cytokine analysis respectively. Infiltrating cells were characterized by immunohistochemistry of harvested corneas at select times post–infection.

Results: : Mice injected with 105 TCID of HAdV–37 developed corneal stromal opacities beginning 1 day after injection. Opacities peaked by 3–4 days post–infection, but persisted for up to one month. Buffer–injected corneas remained clear. By real–time PCR, mRNAs for IL–6 and KC were elevated over buffer–injected controls by 4 hours post–infection (3.12 +/– 0.85 and 3.04 +/– 0.39 fold–elevated, respectively) At the same time point, we detected adenoviral mRNAs for E1A and E1B 19k, but not IIIa. Immunohistochemistry performed 4 days post–infection revealed patchy infiltration of neutrophils in the subepithelial corneal stroma and a few scattered CD3–positive cells only in HAdV–37 injected corneas.

Conclusions: : We describe a new mouse model of HAdV–37 keratitis that will allow us to study host mechanisms for innate immune responses to infection in the absence of viral replication.

Keywords: adenovirus • keratitis • cornea: stroma and keratocytes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×